ArticleInternational ophthalmology2025
Changes in optical coherence tomography (OCT) parameters in follow-up of acute posterior multifocal placoid pigment epitheliopathy (APMPPE).
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate retinal and choroidal optical coherence tomography (OCT) parameters in eyes with acute posterior multifocal placoid pigment epitheliopathy (APMPPE) and their changes during the follow-up.
methodsBest corrected visual acuity (BCVA- Snellen), central macular thickness (CMT), central choroidal thickness (CCT), total choroidal area (TCA), and choroidal vascularity index (CVI) and the other clinical findings were recorded at baseline and month 1, month 3, and year 1.
resultsTwenty-two eyes of 11 patients were included in this study. The mean follow-up period was 18.3 ± 11.9 months. While the mean BCVA value was 0.54 at the initial visit; it improved statistically significantly to 0.74 at the 3rd-month visit (p = 0.025). The highest levels of CMT, CCT, TCA and CVI were at baseline. Statistically significant decreases were observed in CMT at month 3 and in choroidal parameters at month 1 (p < 0.05, for each). Baseline and 1-year CMT values were positively correlated with 1-year BCVA (p = 0.001, r = 0.80 and p = 0.013, r = 0.67; respectively).
conclusionThe acute phase of APMPPE disease is associated with increased retinal thickness and choroidal thickness, area, and vascularity. These parameters, which can be obtained non-invasively, can be valuable in the follow-up period.
Indexed as
Identifiers
40844668What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.